Our results indicated that mouse IgA, especially rW27, not only controlled the gut microbiota but also suppressed the increase in lipocalin 2 level, which is a significant finding that raises the possibility of treatment of IBD. The gene discussed is CD79A; the disease is inflammatory bowel disease.